Portal de Periódicos da CAPES

E-cigarette use related lung disease, review of clinical and imaging findings in 3 cases

2020; Elsevier BV; Volume: 49; Issue: 2 Linguagem: Inglês

10.1016/j.hrtlng.2020.01.005

1527-3288

Kianoush Ansari‐Gilani, Andrew Petraszko, Catalina V. Teba, Allen R. Reeves, Amit Gupta, Aekta Gupta, Nikhil H. Ramaiya, Robert Gilkeson,

Smoking Behavior and Cessation

Electronic-cigarette use (vaping), has gained popularity among the young adult population, causing an alarming rise in electronic-cigarette, or vaping, product use-associated lung injury (EVALI). The specific chemical agent(s) responsible for lung injuries remains to be further investigated, but tetrahydrocannabinol, the active ingredient in marijuana, and vitamin E acetate are involved in most cases. A variety of pulmonary diseases causing different imaging findings have been described with EVALI. The clinical and imaging findings of three cases recently seen in our emergency department are reviewed.